Apolipoprotein J inhibits the migration, adhesion, and proliferation of vascular smooth muscle cells

Journal of Vascular Surgery

Volumn 34, Issue 4, 2001, Pages 716-723

  Sivamurthy, Nayan ^a,c   Stone, David H ^a,c   LoGerfo, Frank W ^a,c   Quist, William C ^a,b,c,d  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; CLU PROTEIN, HUMAN; CLUSTERIN; COLLAGEN; GLYCOPROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET-DERIVED GROWTH FACTOR BB;

AORTA; ARTICLE; BLOOD VESSEL TRANSPLANTATION; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS MATRIX; CHEMOTAXIS; CULTURE TECHNIQUE; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; INJURY; INTIMA; METHODOLOGY; PHYSIOLOGY; TIME; VASCULAR SMOOTH MUSCLE;

AORTA; BLOOD VESSEL PROSTHESIS IMPLANTATION; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHEMOTAXIS; CLUSTERIN; COLLAGEN; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; MOLECULAR CHAPERONES; MUSCLE, SMOOTH, VASCULAR; NUCLEAR MATRIX; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET-DERIVED GROWTH FACTOR; TIME FACTORS; TRANSCRIPTION, GENETIC; TUNICA INTIMA;

EID: 0035490604     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2001.116301     Document Type: Article

References (33)

1. LoGerfo FW, Quist WC, Nowak MD, Crawshaw H, Haudenschild CC. Downstream anastomotic intimal hyperplasia: a mechanism of failure in Dacron arterial grafts. Ann Surg 1983;197:479.
2. Cordero JA, Quist WC, Hamdan AD, Phaneuf MD, Contreras MA, LoGerfo FW. Identification of multiple genes with altered expression at the distal anastomosis of healing polytetrafluoroethylene grafts. J Vasc Surg 1998;28:157-66.
3. Hamdan AD, Aiello LP, Quist WC, Ozaki CK, Contreras MA, Phaneuf MD, et al. Isolation of genes differentially expressed at the downstream anastomosis of prosthetic arterial grafts with use of mRNA differential display. J Vasc Surg 1995;21:228-34.
4. Granholm NA, Zhu B, Aronow B, Harmony JAK, Hui DY. Apolipoprotein J/Clusterin protects against neointima hyperplasia in the vascular response to arterial injury. Circulation 2000;102(Suppl II):II-316.
5. Blaschuk O, Burdzy K, Fritz IB. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem 1983;12:7714-20.
6. DeSilva HV, Stuart WD, Park YB, Mao SJ, Gil CM, Wettrau JR, et al. Purification and characterization of apolipoprotein J. J Biol Chem 1990;265:14292-7.
7. Rosenberg ME, Silkensen J. Clusterin: physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 1995;27:633-45.
8. Ishikawa Y, Akasaka Y, Ishii T, Komiyama K, Masuda S, Asuwa N, et al. Distribution and synthesis of apolipoprotein J in the atherosclerotic aorta. Arterioscler Thromb Vasc Biol 1998;18:665-72.
9. Witte DP, Aronow BJ, Stauderman ML, Stuart WD, Clay MA, Gruppo RA, et al. Platelet aggregation releases megakaryocyte synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am J Pathol 1993;143:763-73.
10. Diemer V, Hoyle M, Baglioni C, Millis AJT. Expression of porcine complement cytolysis inhibitor mRNA in cultured aortic smooth muscle cells. J Biol Chem 1992;267:5257-64.
11. Silkensen JR, Hirsch AT, Lunzer MM, Chmielewski D, Manivel JC, Muellerleile MR, et al. Temporal induction of clusterin in the periinfart zone after experimental myocardial infarction in the rat. J Lab Clin Med 1998;131:28-35.
12. Schwochau GB, Nath KA, Rosenberg ME. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. Kidney Int 1998;53:1647-53.
13. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti J, Schifferli J, et al. Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 1999;112:290-6.
14. McDonald JF, Nelsestuen GL. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization. Biochemistry 1997;36:7464-73.
15. Moulson CL, Millis AJ. Clusterin (apo J) regulates vascular smooth muscle cell differentiation in vitro. J Cell Physiol 1999;180:355-64.
16. Thomas-Salgar S, Millis AJ. Clusterin expression in differentiating smooth muscle cells. J Biol Chem 1994;269:17879-85.
17. Silkensen JR, Skubitz KM, Skubitz APN, Chmielewski DH, Manivel JC, Dvergsten JA, et al. Clusterin promotes the aggregation and adhesion of renal porcine epithelial cells. J Clin Invest 1992;96:2646-53.
18. Pauly RR, Passaniti A, Bilato C, Monticone R, Cheng L, Papadopoulos N, et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collage -nase activity and is inhibited by cellular differentiation. Circ Res 1994;75:41-54.
19. 1 phase. J Biol Chem 1998;273:20156-61.
20. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996;14:1675-80.
21. Affymetrix. Gene chip 3.1 expression analysis algorithm tutorial. Santa Clara, Calif; 1999.
22. Tung PS, Burdzy K, Wong K, Fritz IB. Competition between cell-substratum interactions and cell-cell interactions. J Cell Physiol 1992;152:410-21.
23. Bettuzzi S, Astancolle S, Guidetti G, Moretti M, Tiozzo R, Corti A. Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts. FEBS Lett 1999;448:297-300.
24. Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR. Clusterin has chape rone-like activity similar to that of small heat shock proteins. J Biol Chem 1999;274:6875-81.
25. Choi N, Tobe T, Hara K, Yoshida H, Tomita M. Sandwich Elisa for quantitative measurement of sp40,40 in seminal fluid and serum. J Immunol Methods 1990;131:159-63.
26. Iyer VR, Eisen MD, Ross DT, Schuler G, Moore T, Lee JCF, et al. The transcriptional program in the response of human fibroblasts to serum. Science 1999;283:83-7.
27. Feng Y, Yang JH, Huang H, Kennedy SP, Turi TG, Thompson JF, et al. Transcriptional profile of mechanically induced genes in human vascular smooth muscle cells. Circ Res 1999;85:1118-23.
28. Coller HA, Grandori C, Tamayo P, Colbert T, Lander ES, Eisenman RN, et al. Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A 2000;97:3260-5.
29. Schonbeck U, Brandt E, Petersen F, Flad HD, Loppnow H. IL-8 specifically binds to endothelial but not to smooth muscle cells. J Immunol 1995;154:2375-83.
30. Yue TL, Mckenna PJ, Gu JL, Feuerstein GZ. Interleukin-8 is chemotactic for vascular smooth muscle cells. Eur J Pharmacol 1993;240:81-4.
31. Woods M, Mitchell JA, Wood EG, Barker S, Walcot NR, Rees GM, et al. Endothelin-1 is induced by cytokines in human vascular smooth muscle cells: evidence for intracellular endothelin-converting enzyme. Mol Pharmacol 1999;55:902-9.
32. Hahn AW, Regenass S, Resnick TJ, Kern F, Buhler FR. Morphogenic effects of endothelin-1 on vascular smooth muscle cells. J Vasc Res 1993;30:192-201.
33. Shichiri M, Yokokura M, Marumo F, Hirata Y. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 2000;20:989-97.